Literature DB >> 24065580

Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.

Amy K Licis1, Alicia Vallorani, Feng Gao, Cynthia Chen, Jason Lenox, Kelvin A Yamada, Stephen P Duntley, David H Gutmann.   

Abstract

Children with neurodevelopmental disorders are at increased risk for sleep issues, which affect quality of life, cognitive function, and behavior. To determine the prevalence of sleep problems in children with the common neurodevelopmental disorder neurofibromatosis type 1, a cross-sectional study was performed on 129 affected subjects and 89 unaffected siblings, age 2 to 17 years, using the Sleep Disturbance Scale for Children questionnaire. Children with neurofibromatosis type 1 were significantly more likely to have disturbances in initiating and maintaining sleep, arousal, sleep-wake transition, and hyperhidrosis, but not problems with abnormal sleep breathing, or excessive somnolence. Although the overall sleep scores were higher in children with neurofibromatosis type 1, this was not related to a coexisting attention deficit disorder, cognitive impairment, or stimulant medication use. Collectively, these results demonstrate that children with neurofibromatosis type 1 are more likely to have sleep disturbances, and support the use of appropriate interventions for this at-risk population.

Entities:  

Keywords:  NF1; brain tumor; neurocutaneous disorders; sleep disturbances

Year:  2013        PMID: 24065580      PMCID: PMC3805763          DOI: 10.1177/0883073813500849

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  37 in total

1.  Effects of sleep-disordered breathing on physical traits, school performance, and behavior of Korean elementary school students in the upper grade levels.

Authors:  Jin Kook Kim; Ji Hye Lee; Seung-Hoon Lee; Seok-Chan Hong; Jae Hoon Cho
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-05       Impact factor: 1.547

2.  The meaning of night sweats.

Authors:  I R McWhinney
Journal:  Can Fam Physician       Date:  2005-02       Impact factor: 3.275

Review 3.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.

Authors:  K N North; V Riccardi; C Samango-Sprouse; R Ferner; B Moore; E Legius; N Ratner; M B Denckla
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Neurofibromatosis: implications for learning and behavior.

Authors:  M J Eliason
Journal:  J Dev Behav Pediatr       Date:  1986-06       Impact factor: 2.225

5.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Authors:  Shelley L Hyman; Arthur Shores; Kathryn N North
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

Review 6.  Parasomnias and other sleep-related movement disorders.

Authors:  Teofilo L Lee-Chiong
Journal:  Prim Care       Date:  2005-06       Impact factor: 2.907

7.  The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence.

Authors:  O Bruni; S Ottaviano; V Guidetti; M Romoli; M Innocenzi; F Cortesi; F Giannotti
Journal:  J Sleep Res       Date:  1996-12       Impact factor: 3.981

8.  Associations between night sweats and other sleep disturbances: An OKPRN study.

Authors:  James W Mold; Joseph H Woolley; Zsolt Nagykaldi
Journal:  Ann Fam Med       Date:  2006 Sep-Oct       Impact factor: 5.166

9.  Neurobehavioral function is impaired in children with all severities of sleep disordered breathing.

Authors:  Robert S Bourke; Vicki Anderson; Joel S C Yang; Angela R Jackman; Asawari Killedar; Gillian M Nixon; Margot J Davey; Adrian M Walker; John Trinder; Rosemary S C Horne
Journal:  Sleep Med       Date:  2011-02-15       Impact factor: 3.492

10.  Child behavior and quality of life before and after tonsillectomy and adenoidectomy.

Authors:  Nira A Goldstein; Mahnur Fatima; Thomas F Campbell; Richard M Rosenfeld
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07
View more
  11 in total

1.  Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation.

Authors:  Corina Anastasaki; Nicholas Rensing; Kevin J Johnson; Michael Wong; David H Gutmann
Journal:  J Sleep Res       Date:  2019-01-04       Impact factor: 3.981

2.  Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Authors:  Corina Anastasaki; David H Gutmann
Journal:  Hum Mol Genet       Date:  2014-07-28       Impact factor: 6.150

3.  Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review.

Authors:  Carmen Sílvia Miguel; Tiffany M Chaim-Avancini; Maria Aparecida Silva; Mario Rodrigues Louzã
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-25       Impact factor: 2.570

4.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

5.  Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients.

Authors:  Máximo Zimerman; Maximilian J Wessel; Jan E Timmermann; Sofia Granström; Christian Gerloff; Victor F Mautner; Friedhelm C Hummel
Journal:  EBioMedicine       Date:  2015-09-01       Impact factor: 8.143

Review 6.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

7.  A Conserved Circadian Function for the Neurofibromatosis 1 Gene.

Authors:  Lei Bai; Yool Lee; Cynthia T Hsu; Julie A Williams; Daniel Cavanaugh; Xiangzhong Zheng; Carly Stein; Paula Haynes; Han Wang; David H Gutmann; Amita Sehgal
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

8.  Sleep disorders in rare genetic syndromes: a meta-analysis of prevalence and profile.

Authors:  Georgie Agar; Chloe Brown; Daniel Sutherland; Sean Coulborn; Chris Oliver; Caroline Richards
Journal:  Mol Autism       Date:  2021-02-25       Impact factor: 7.509

9.  Neurofibromatosis type I: points to be considered by general pediatricians.

Authors:  Eungu Kang; Hee Mang Yoon; Beom Hee Lee
Journal:  Clin Exp Pediatr       Date:  2020-07-15

10.  Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.

Authors:  Lei Bai; Amita Sehgal
Journal:  PLoS Genet       Date:  2015-11-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.